199 related articles for article (PubMed ID: 10816133)
1. Replicative senescence as a barrier to human cancer.
Parkinson EK; Munro J; Steeghs K; Morrison V; Ireland H; Forsyth N; Fitzsimmons S; Bryce S
Biochem Soc Trans; 2000 Feb; 28(2):226-33. PubMed ID: 10816133
[TBL] [Abstract][Full Text] [Related]
2. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; Catricalà C; O'Toole KM
Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
[TBL] [Abstract][Full Text] [Related]
3. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
4. Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization.
Munro J; Stott FJ; Vousden KH; Peters G; Parkinson EK
Cancer Res; 1999 Jun; 59(11):2516-21. PubMed ID: 10363964
[TBL] [Abstract][Full Text] [Related]
5. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
[TBL] [Abstract][Full Text] [Related]
6. P16(INK4A) is implicated in both the immediate and adaptative response of human keratinocytes to UVB irradiation.
Chazal M; Marionnet C; Michel L; Mollier K; Dazard JE; Della Valle V; Larsen CJ; Gras MP; Basset-Séguin N
Oncogene; 2002 Apr; 21(17):2652-61. PubMed ID: 11965538
[TBL] [Abstract][Full Text] [Related]
7. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
[TBL] [Abstract][Full Text] [Related]
8. Immortalization of human mammary epithelial cells is associated with inactivation of the p14ARF-p53 pathway.
Shamanin VA; Androphy EJ
Mol Cell Biol; 2004 Mar; 24(5):2144-52. PubMed ID: 14966292
[TBL] [Abstract][Full Text] [Related]
9. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.
Oruetxebarria I; Venturini F; Kekarainen T; Houweling A; Zuijderduijn LM; Mohd-Sarip A; Vries RG; Hoeben RC; Verrijzer CP
J Biol Chem; 2004 Jan; 279(5):3807-16. PubMed ID: 14604992
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
11. Contribution of p16INK4a and p21CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53.
Chen J; Huang X; Halicka D; Brodsky S; Avram A; Eskander J; Bloomgarden NA; Darzynkiewicz Z; Goligorsky MS
Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1575-86. PubMed ID: 16243918
[TBL] [Abstract][Full Text] [Related]
12. [Cyclin dependent kinase inhibitors and replicative senescence].
Gerland LM; Ffrench M; Magaud JP
Pathol Biol (Paris); 2001 Dec; 49(10):830-9. PubMed ID: 11776695
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
Pare R; Shin JS; Lee CS
Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
[TBL] [Abstract][Full Text] [Related]
14. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E
Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressors and oncogenes in cellular senescence.
Bringold F; Serrano M
Exp Gerontol; 2000 May; 35(3):317-29. PubMed ID: 10832053
[TBL] [Abstract][Full Text] [Related]
16. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.
Dickson MA; Hahn WC; Ino Y; Ronfard V; Wu JY; Weinberg RA; Louis DN; Li FP; Rheinwald JG
Mol Cell Biol; 2000 Feb; 20(4):1436-47. PubMed ID: 10648628
[TBL] [Abstract][Full Text] [Related]
17. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
18. Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes.
Chaturvedi V; Cesnjaj M; Bacon P; Panella J; Choubey D; Diaz MO; Nickoloff BJ
Am J Pathol; 2003 Jan; 162(1):161-70. PubMed ID: 12507899
[TBL] [Abstract][Full Text] [Related]
19. Replicative senescence in human uroepithelial cells.
Puthenveettil JA; Burger MS; Reznikoff CA
Adv Exp Med Biol; 1999; 462():83-91. PubMed ID: 10599415
[TBL] [Abstract][Full Text] [Related]
20. Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms.
Davis T; Singhrao SK; Wyllie FS; Haughton MF; Smith PJ; Wiltshire M; Wynford-Thomas D; Jones CJ; Faragher RG; Kipling D
J Cell Sci; 2003 Apr; 116(Pt 7):1349-57. PubMed ID: 12615976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]